Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present data from its late-stage antibiotics pipeline at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, May 10-13. Data highlighted will offer insights into Cubist’s research and development programs, which focus on Gram-positive and Gram-negative bacteria that cause serious and complicated infections.
Help employers find you! Check out all the jobs and post your resume.
